- Home
- TONX vs INO Comparison
TONX vs INO Comparison
Compare TONX & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TONX | INO |
|---|---|---|
| Founded | N/A | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 136.5M | 116.1M |
| IPO Year | N/A | 1998 |
Fundamental Metrics
Financial Performance| Metric | TONX | INO |
|---|---|---|
| Price | $1.96 | $1.66 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 493.0K | ★ 1.2M |
| Earning Date | 03-24-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 7.29 | N/A |
| Revenue | ★ $7,760,000.00 | $182,337.00 |
| Revenue This Year | $526.82 | N/A |
| Revenue Next Year | $45.45 | $23,060.18 |
| P/E Ratio | $0.27 | ★ N/A |
| Revenue Growth | ★ 3760.70 | N/A |
| 52 Week Low | $1.78 | $1.30 |
| 52 Week High | $29.77 | $2.98 |
Technical Indicators
Market Signals| Indicator | TONX | INO |
|---|---|---|
| Relative Strength Index (RSI) | 29.15 | 43.81 |
| Support Level | $1.78 | $1.54 |
| Resistance Level | $2.70 | $1.78 |
| Average True Range (ATR) | 0.22 | 0.09 |
| MACD | -0.09 | 0.03 |
| Stochastic Oscillator | 8.84 | 38.71 |
Price Performance
Historical ComparisonAbout TONX TON Strategy Company
TON Strategy Co is a leader in interactive video-based sales applications, transforms how businesses attract and engage customers. The company's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.
About INO Inovio Pharmaceuticals Inc.
Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.